175 related articles for article (PubMed ID: 38374995)
1. Overexpression of VEGFα as a biomarker of endothelial dysfunction in aortic tissue of α-GAL-Tg/KO mice and its upregulation in the serum of patients with Fabry's disease.
Lund N; Wieboldt H; Fischer L; Muschol N; Braun F; Huber T; Sorriento D; Iaccarino G; Müllerleile K; Tahir E; Adam G; Kirchhof P; Fabritz L; Patten M
Front Cardiovasc Med; 2024; 11():1355033. PubMed ID: 38374995
[TBL] [Abstract][Full Text] [Related]
2. Identification of Fabry's disease by the screening of alpha-galactosidase A activity in male and female hemodialysis patients.
Tanaka M; Ohashi T; Kobayashi M; Eto Y; Miyamura N; Nishida K; Araki E; Itoh K; Matsushita K; Hara M; Kuwahara K; Nakano T; Yasumoto N; Nonoguchi H; Tomita K
Clin Nephrol; 2005 Oct; 64(4):281-7. PubMed ID: 16240899
[TBL] [Abstract][Full Text] [Related]
3. [Ocular findings in Fabry's disease].
Kuzman T; Juri J; Mrsić M; Jeren-Strujić B; Mandić Z; Sikić J
Acta Med Croatica; 2006; 60(2):163-6. PubMed ID: 16848212
[TBL] [Abstract][Full Text] [Related]
4. Screening Fabry's disease in chronic kidney disease patients not on dialysis: a multicenter study.
Yeniçerioğlu Y; Akdam H; Dursun B; Alp A; Sağlam Eyiler F; Akın D; Gün Y; Hüddam B; Batmazoğlu M; Gibyeli Genek D; Pirinççi S; Ersoy İR; Üzüm A; Soypaçacı Z; Tanrısev M; Çolak H; Demiral Sezer S; Bozkurt G; Akyıldız UO; Akyüz Ünsal Aİ; Ünübol M; Uslu M; Eryılmaz U; Günel C; Meteoğlu İ; Yavaşoğlu İ; Ünsal A; Akar H; Okyay P
Ren Fail; 2017 Nov; 39(1):104-111. PubMed ID: 27832731
[TBL] [Abstract][Full Text] [Related]
5. Decline of plasma brain natriuretic peptide during enzyme replacement therapy in a female patient with heterozygous Fabry's disease.
Masugata H; Senda S; Goda F; Yamagami A; Okuyama H; Kohno T; Hosomi N; Yukiiri K; Noma T; Murao K; Kohno M; Itoh S
Tohoku J Exp Med; 2009 Mar; 217(3):169-74. PubMed ID: 19282651
[TBL] [Abstract][Full Text] [Related]
6. Enzyme replacement therapy in Fabry's disease: recent advances and clinical applications.
Mignani R; Cagnoli L
J Nephrol; 2004; 17(3):354-63. PubMed ID: 15365954
[TBL] [Abstract][Full Text] [Related]
7. Enzyme replacement therapy in patients with Fabry's disease.
Tsuboi K
J Int Med Res; 2007; 35(4):574-81. PubMed ID: 17697536
[TBL] [Abstract][Full Text] [Related]
8. Endothelial nitric oxide synthase gene polymorphisms in Fabry's disease.
Heltianu C; Costache G; Azibi K; Poenaru L; Simionescu M
Clin Genet; 2002 Jun; 61(6):423-9. PubMed ID: 12121349
[TBL] [Abstract][Full Text] [Related]
9. Cardiopulmonary involvement in Fabry's disease.
Koskenvuo JW; Kantola IM; Nuutila P; Knuuti J; Parkkola R; Mononen I; Hurme S; Kalliokoski R; Viikari JS; Wendelin-Saarenhovi M; Kiviniemi TO; Hartiala JJ
Acta Cardiol; 2010 Apr; 65(2):185-92. PubMed ID: 20458826
[TBL] [Abstract][Full Text] [Related]
10. Dysregulated autophagy contributes to podocyte damage in Fabry's disease.
Liebau MC; Braun F; Höpker K; Weitbrecht C; Bartels V; Müller RU; Brodesser S; Saleem MA; Benzing T; Schermer B; Cybulla M; Kurschat CE
PLoS One; 2013; 8(5):e63506. PubMed ID: 23691056
[TBL] [Abstract][Full Text] [Related]
11. [A case of Fabry's disease with chronic renal failure].
Suzuki T; Fujino T; Sugasawa M; Kohara Y; Toyama K; Sato T; Yasuda T; Sugiyama M; Maeba T; Owada S; Ishida M
Nihon Jinzo Gakkai Shi; 1999 Jun; 41(4):448-53. PubMed ID: 10441995
[TBL] [Abstract][Full Text] [Related]
12. Genetics and Gene Therapy of Anderson-Fabry Disease.
Simonetta I; Tuttolomondo A; Di Chiara T; Miceli S; Vogiatzis D; Corpora F; Pinto A
Curr Gene Ther; 2018; 18(2):96-106. PubMed ID: 29618309
[TBL] [Abstract][Full Text] [Related]
13. [Effect of enzyme replacement therapy (ERT) on renal function of patients with Fabry's disease].
Thomaidis T; Relle M; Reinke J; Beck M; Schwarting A
Med Klin (Munich); 2009 Sep; 104(9):699-703. PubMed ID: 19779674
[TBL] [Abstract][Full Text] [Related]
14. Restricted accumulation of globotriaosylceramide in the hearts of atypical cases of Fabry's disease.
Ogawa K; Sugamata K; Funamoto N; Abe T; Sato T; Nagashima K; Ohkawa S
Hum Pathol; 1990 Oct; 21(10):1067-73. PubMed ID: 2120125
[TBL] [Abstract][Full Text] [Related]
15. Association of renal ectopia with Fabry's disease in 3 patients.
Rákóczi E; Tóth B; Görögh S; Erdos M; Sümegi J; Maródi L
J Urol; 2009 Apr; 181(4):1949-54. PubMed ID: 19237168
[TBL] [Abstract][Full Text] [Related]
16. Fabry's disease.
Adam T; Alexandrescu L; Voinea F; Toringhibel M; Hâncu A
Rom J Intern Med; 2006; 44(4):455-64. PubMed ID: 18386622
[TBL] [Abstract][Full Text] [Related]
17. Unexplained left ventricular hypertrophy: consider a diagnosis of Fabry's disease.
Linthorst GE; Vedder AC; Bouma BJ; Dekker LR; Hollak CE
Neth Heart J; 2006 Mar; 14(3):100-105. PubMed ID: 25696603
[TBL] [Abstract][Full Text] [Related]
18. Molecular genetic, biochemical, and clinical studies in three families with cardiac Fabry's disease.
Yoshitama T; Nakao S; Takenaka T; Teraguchi H; Sasaki T; Kodama C; Tanaka A; Kisanuki A; Tei C
Am J Cardiol; 2001 Jan; 87(1):71-5. PubMed ID: 11137837
[TBL] [Abstract][Full Text] [Related]
19. Neurological manifestations in Fabry's disease.
Møller AT; Jensen TS
Nat Clin Pract Neurol; 2007 Feb; 3(2):95-106. PubMed ID: 17279083
[TBL] [Abstract][Full Text] [Related]
20. Ocular manifestations of Fabry's disease: data from the Fabry Outcome Survey.
Sodi A; Ioannidis AS; Mehta A; Davey C; Beck M; Pitz S
Br J Ophthalmol; 2007 Feb; 91(2):210-4. PubMed ID: 16973664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]